These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

510 related items for PubMed ID: 9462239

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Epstein-Barr virus latent membrane protein-1 oncogene deletion in post-transplantation lymphoproliferative disorders.
    Scheinfeld AG, Nador RG, Cesarman E, Chadburn A, Knowles DM.
    Am J Pathol; 1997 Sep; 151(3):805-12. PubMed ID: 9284829
    [Abstract] [Full Text] [Related]

  • 24. Heterogeneous Epstein-Barr virus latent gene expression in AIDS-associated lymphomas and in type I Burkitt's lymphoma cell lines.
    Touitou R, Arbach H, Cochet C, Feuillard J, Martin A, Raphaël M, Joab I.
    J Gen Virol; 2003 Apr; 84(Pt 4):949-957. PubMed ID: 12655096
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Detection of a nuclear antigen 2 (EBNA2)-variant Epstein-Barr virus strain in two siblings with fatal lymphoproliferative disease.
    Schuster V, Seidenspinner S, Kreth HW.
    J Med Virol; 1996 Jan; 48(1):114-20. PubMed ID: 8825720
    [Abstract] [Full Text] [Related]

  • 27. Epstein-Barr virus (EBV) gene expression in EBV-positive peripheral T-cell lymphomas.
    Chen CL, Sadler RH, Walling DM, Su IJ, Hsieh HC, Raab-Traub N.
    J Virol; 1993 Oct; 67(10):6303-8. PubMed ID: 8396685
    [Abstract] [Full Text] [Related]

  • 28. Epstein-Barr virus presence in pediatric diffuse large B-cell lymphoma reveals a particular association and latency patterns: analysis of viral role in tumor microenvironment.
    Cohen M, De Matteo E, Narbaitz M, Carreño FA, Preciado MV, Chabay PA.
    Int J Cancer; 2013 Apr 01; 132(7):1572-80. PubMed ID: 22987474
    [Abstract] [Full Text] [Related]

  • 29. Epstein-Barr virus infection and associated products (LMP, EBNA2, vIL-10) in nodal non-Hodgkin's lymphoma of human immunodeficiency virus-negative Japanese.
    Ohshima K, Suzumiya J, Tasiro K, Mukai Y, Tanaka T, Kato A, Kikuchi M.
    Am J Hematol; 1996 May 01; 52(1):21-8. PubMed ID: 8638607
    [Abstract] [Full Text] [Related]

  • 30. Expression of Epstein-Barr virus latent genes and adhesion molecules in AIDS-related non-Hodgkin's lymphomas: correlation with histology and CD4-cell number.
    Kersten MJ, Van Gorp J, Pals ST, Boon F, Van Oers MH.
    Leuk Lymphoma; 1998 Aug 01; 30(5-6):515-24. PubMed ID: 9711914
    [Abstract] [Full Text] [Related]

  • 31. [Role of Epstein-Barr Virus in lymphoproliferative disorders].
    Raphael M.
    Bull Acad Natl Med; 1997 Aug 01; 181(6):999-1007; discussion 1007-8. PubMed ID: 9453845
    [Abstract] [Full Text] [Related]

  • 32. Epstein-Barr virus nuclear antigen 2 (EBNA2) gene deletion is consistently linked with EBNA3A, -3B, and -3C expression in Burkitt's lymphoma cells and with increased resistance to apoptosis.
    Kelly GL, Milner AE, Tierney RJ, Croom-Carter DS, Altmann M, Hammerschmidt W, Bell AI, Rickinson AB.
    J Virol; 2005 Aug 01; 79(16):10709-17. PubMed ID: 16051863
    [Abstract] [Full Text] [Related]

  • 33. Epstein-Barr virus-latent gene expression and tumor cell phenotype in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Correlation of lymphoma phenotype with three distinct patterns of viral latency.
    Hamilton-Dutoit SJ, Rea D, Raphael M, Sandvej K, Delecluse HJ, Gisselbrecht C, Marelle L, van Krieken HJ, Pallesen G.
    Am J Pathol; 1993 Oct 01; 143(4):1072-85. PubMed ID: 8214003
    [Abstract] [Full Text] [Related]

  • 34. Polymorphism analysis of Epstein-Barr virus isolates from patients with cutaneous natural killer/T-cell lymphoproliferative disorders: A possible relation to the endemic occurrence of these diseases in Japan.
    Xu ZG, Iwatsuki K, Ohtsuka M, Oyama N, Matsui T, Kaneko F.
    J Med Virol; 2000 Oct 01; 62(2):239-46. PubMed ID: 11002254
    [Abstract] [Full Text] [Related]

  • 35. EBV-NK cells interactions and lymphoproliferative disorders.
    Kanegane H, Yachie A, Miyawaki T, Tosato G.
    Leuk Lymphoma; 1998 May 01; 29(5-6):491-8. PubMed ID: 9643562
    [Abstract] [Full Text] [Related]

  • 36. Epstein-Barr virus (EBV) infection in B-cell non-Hodgkin's lymphomas in children: virus latency and its correlation with CD21 and CD23 molecules.
    Kasprzak A, Spachacz R, Wachowiak J, Stefanska K, Zabel M.
    Folia Histochem Cytobiol; 2007 May 01; 45(3):169-79. PubMed ID: 17951165
    [Abstract] [Full Text] [Related]

  • 37. Evidence for restricted Epstein-Barr virus latent gene expression and anti-EBNA antibody response in solid organ transplant recipients with posttransplant lymphoproliferative disorders.
    Cen H, Williams PA, McWilliams HP, Breinig MC, Ho M, McKnight JL.
    Blood; 1993 Mar 01; 81(5):1393-403. PubMed ID: 8382973
    [Abstract] [Full Text] [Related]

  • 38. A20 (TNFAIP3) deletion in Epstein-Barr virus-associated lymphoproliferative disorders/lymphomas.
    Ando M, Sato Y, Takata K, Nomoto J, Nakamura S, Ohshima K, Takeuchi T, Orita Y, Kobayashi Y, Yoshino T.
    PLoS One; 2013 Mar 01; 8(2):e56741. PubMed ID: 23418597
    [Abstract] [Full Text] [Related]

  • 39. Expression of the simian Epstein-Barr virus-encoded latent membrane protein-1 in malignant lymphomas of SIV-infected rhesus macaques.
    Blaschke S, Hannig H, Buske C, Kaup FJ, Hunsmann G, Bodemer W.
    J Med Virol; 2001 Sep 01; 65(1):114-20. PubMed ID: 11505452
    [Abstract] [Full Text] [Related]

  • 40. Biology and adoptive cell therapy of Epstein-Barr virus-associated lymphoproliferative disorders in recipients of marrow allografts.
    O'Reilly RJ, Small TN, Papadopoulos E, Lucas K, Lacerda J, Koulova L.
    Immunol Rev; 1997 Jun 01; 157():195-216. PubMed ID: 9255631
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.